Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Ocugen is a biotechnology company that develops novel gene and cell therapies to improve health and patient outcomes.
Think Bioscience is reimagining synthetic biology by guiding the design and assembly of better medicines through the use of living systems.
Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.
Developing the next-generation, AI-enabled commercial space station
CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
Yarrow is developing a first-in-class antibody targeting TSHR for the treatment of Graves’ disease and thyroid eye disease.
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.
Ambros Therapeutics is a clinical-stage biotechnology company.
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.
Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.
Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.
Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.
Bambusa Therapeutics operates as biotechnology company.
Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process.
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
Sonoma Biotherapeutics develops engineered regulatory T-cell (Treg) therapies to treat autoimmune and inflammatory diseases.
MindMed provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Owlet Baby Care offers a health monitor that allows parents to view their child's vital signs in real-time.
LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.
AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.
Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.
Janus Henderson Investors has invested in 227 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Janus Henderson Investors's top investment sectors include Biotechnology, Therapeutics, Health Care, Life Science, Medical. The firm invests across 19 different industry categories.
Among tracked funding rounds, Structure Therapeutics received $747.5M in a Post Ipo Equity round. Janus Henderson Investors's total known invested capital is $31.3B.
Janus Henderson Investors's average investment size is $160.4M across its portfolio of 227 companies.
Recent Janus Henderson Investors portfolio additions include Ocugen, Think Bioscience, Diagonal Therapeutics, Starlab Space, CAMP4 Therapeutics. These companies were founded in 2020 or later.